Tumor-selective, chaperone-mediated targeting of ERK5 (MAPK7)

Foley, KP; Yang, XC; Yin, W; Xu, MM; Wang, MK; Ding, QL; Dai, Y; Zhou, HX; Tusa, I; Menconi, A; Lombardi, Z; Tubita, A; Prince, TL; Wang, GQ; Rovida, E; Ying, WW

MOLECULAR CANCER THERAPEUTICS, 2023; 22 (12):